Atlas Trials

Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults

Clinical trial NCT00695877 · COMPLETED

Trial details

NCT number
NCT00695877
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections
Start date
2009-02-08
Primary completion
2012-12-11
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.